Pure Global

A Study to Evaluate the Drug Interaction Between Povorcitinib and the Oral Contraceptive Levonorgestrel/Ethinyl Estradiol in Healthy Adult Females - Trial NCT06380205

Access comprehensive clinical trial information for NCT06380205 through Pure Global AI's free database. This Phase 1 trial is sponsored by Incyte Corporation and is currently Recruiting. The study focuses on Healthy Participants. Target enrollment is 24 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06380205
Phase 1
Recruiting
drug
Trial Details
ClinicalTrials.gov โ€ข NCT06380205
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
A Study to Evaluate the Drug Interaction Between Povorcitinib and the Oral Contraceptive Levonorgestrel/Ethinyl Estradiol in Healthy Adult Females
A Phase 1, Open-Label Study to Evaluate the Drug Interaction Between Povorcitinib and the Oral Contraceptive Levonorgestrel/Ethinyl Estradiol in Healthy Adult Females

Study Focus

Healthy Participants

Povorcitinib

Interventional

drug

Sponsor & Location

Incyte Corporation

Tempe, United States of America

Timeline & Enrollment

Phase 1

May 07, 2024

Jun 07, 2024

24 participants

Primary Outcome

Levonorgestrel (LNG) concentration in plasma,Ethinyl estradiol (EE) concentration in plasma

Summary

The purpose of this study is to evaluate the drug interaction between povorcitinib and the
 oral contraceptive levonorgestrel/ethinyl estradiol in healthy adult females.

ICD-10 Classifications

Seeking and accepting physical, nutritional and chemical interventions known to be hazardous and harmful
Healthy person accompanying sick person
Routine general health check-up of sports teams
Obesity
Persons with potential health hazards related to communicable diseases

Data Source

ClinicalTrials.gov

NCT06380205

Non-Device Trial